Latest Breaking News On - China national biotec group sinopharm - Page 1 : comparemela.com

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

South africaHong kongUniversity of hong kongHong kong generalEmily hendersonClinical professor of department medicineWorld health organizationDivision of infectious diseasesDepartment of microbiologyUniversity of hong kong hkumedHong kong department of healthClinical trials centreChina national biotec group sinopharmChina national biotec groupProfessor ivan hungInfectious diseases

HKU medical research team starts large-scale clinical trial on Covid Vaccine

HKU medical research team starts large-scale clinical trial on Covid Vaccine
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

South africaHong kongUniversity of hong kongHong kong generalHenry yauClinical professor of department medicineWorld health organizationDivision of infectious diseasesResearch methodClinical associate professor of department microbiologyHong kong department of healthDepartment of microbiologyUniversity of hong kong hkumedResearch initiationVaccine developmentClinical trials centre

SAMAA - COVID-19 Pakistan: Who should and shouldn t get the Sinopharm vaccine

COVID-19 Pakistan: Who should and shouldnât get the Sinopharm vaccine It is not recommended for the elderly and pregnant women SAMAA | Health - Posted: Feb 6, 2021 | Last Updated: 2 months ago SAMAA | Health Posted: Feb 6, 2021 | Last Updated: 2 months ago A health worker receives a dose of the Sinopharm vaccine at Dow University of Health Sciences, Karachi. Photo: Online Listen to the story The National Ministry of Health Services and Regulations has released guidelines for the administration of the Sinopharm COVID-19 vaccine being used in Pakistan. The guidelines are based on the current results from clinical trials and might change as new information becomes available.

National ministry of health servicesInstitute of biological productsChina national biotec group sinopharmNational ministryHealth servicesBeijing instituteBiological productsChina national biotec groupதேசிய அமைச்சகம் ஆஃப் ஆரோக்கியம் சேவைகள்நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ்தேசிய அமைச்சகம்ஆரோக்கியம் சேவைகள்பெய்ஜிங் நிறுவனம்உயிரியல் ப்ராடக்ட்ஸ்சீனா தேசிய பயோடெக் குழு